THE ANALOGY
Like peacekeepers stepping in when tempers flare.
You know the moment in the barn aisle when something small turns into a real problem if no one steps in — a horse pinning ears, another threatening to kick. The right person walks in, calmly redirects, and the whole thing ends there.
IL-1 receptor antagonist (IL-1ra) and IL-10 are the molecular version of that. They're potent anti-inflammatory mediators that quiet down inflammatory signaling before it turns into the chronic, low-grade burn that destroys joints and tendons over time.
“Most chronic joint problems aren't a healing problem. They're a stopping problem.”
These two work as a pair. IL-1ra blocks one of the body's most aggressive inflammatory signals. IL-10 broadly suppresses the production of inflammatory mediators. Together, they're how the body restores balance.
HOW THEY WORK IN THE HORSE
What IL-1ra and IL-10 do in tissue
IL-1ra blocks IL-1
IL-1 is one of the most damaging inflammatory signals in joint disease. IL-1ra is the natural antagonist — it occupies the receptor and prevents IL-1 from triggering the cascade.
IL-10 broadly calms inflammation
IL-10 reduces production of multiple inflammatory cytokines, supporting a shift from active inflammation toward resolution.
Together, they restore balance
When these signals are abundant, the body's inflammatory response stays proportional. When they're lacking, inflammation tends to persist and chronic damage follows.
Signals involved in regulating inflammation.
IL-1ra and IL-10 were identified in equicenta® CTM by ELISA (Bertone et al., BMC Medicine, 2025). In the body, these cytokines help regulate inflammatory signaling.
Ask your veterinarian whether equicenta® CTM could be part of your horse's plan.
Every case is different. Your veterinarian is the right person to weigh whether a regenerative approach fits the diagnosis, the rehab plan, and your horse.
Ask a Question